Eton Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q2 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Eton Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q2 2019 to Q3 2024.
  • Eton Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 116 %, a 25.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 116 +23.2 +25.1% Sep 30, 2024
Q2 2024 105 +11.1 +11.8% Jun 30, 2024
Q1 2024 93.5 +1.65 +1.8% Mar 31, 2024
Q4 2023 95.8 +13.4 +16.3% Dec 31, 2023
Q3 2023 92.3 +20.5 +28.6% Sep 30, 2023
Q2 2023 94.2 +26.8 +39.7% Jun 30, 2023
Q1 2023 91.9 +32.9 +55.8% Mar 31, 2023
Q4 2022 82.4 +30 +57.3% Dec 31, 2022
Q3 2022 71.8 +16.9 +30.8% Sep 30, 2022
Q2 2022 67.4 +0.92 +1.38% Jun 30, 2022
Q1 2022 59 -23.9 -28.8% Mar 31, 2022
Q4 2021 52.4 -48 -47.8% Dec 31, 2021
Q3 2021 54.9 -48.8 -47.1% Sep 30, 2021
Q2 2021 66.5 +12.7 +23.5% Jun 30, 2021
Q1 2021 82.9 +51.3 +163% Mar 31, 2021
Q4 2020 100 +78.2 +354% Dec 31, 2020
Q3 2020 104 +92.3 +810% Sep 30, 2020
Q2 2020 53.8 +31.8 +144% Jun 30, 2020
Q1 2020 31.6 Mar 31, 2020
Q4 2019 22.1 Dec 31, 2019
Q3 2019 11.4 Sep 30, 2019
Q2 2019 22.1 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.